UC DAVIS SCIENTIST RECEIVES GRANT AWARD FROM STATE’S STEM CELL AGENCY  
December 12, 2007 —  Stem cell research efforts that could lead to scientific breakthroughs in cancer treatments were among proposals recognized by The California Institute for Regenerative Medicine (CIRM) today when it recognized UC Davis stem cell scientist Chong-xian Pan with one of its New Faculty Awards.

NEW UC DAVIS STUDY FINDS PHYSICIAN STYLE AND HMO AFFILIATION IMPACT LENGTH OF PATIENT VISITS 
December 5, 2007 —  Apart from a more complicated medical case, what makes different physicians spend different amounts of time with their patients?

UC DAVIS TAPPED TO HELP OVERSEE NATIONAL RESEARCH PROJECT FOCUSING ON BURN VICTIMS 
November 28, 2007 —  Supported by recent approval of a $2.4 million federal appropriation, the American Burn Association and UC Davis Regional Burn Center are launching a nationwide research effort aimed at developing new procedures and best practices for the treatment of burn injuries.

PREDICTING RISK OF HIP FRACTURE IN POSTMENOPAUSAL WOMEN
November 27, 2007 —  To help doctors predict the five-year risk of hip fractures in their postmenopausal patients, a team of UC Davis researchers has developed a method that assesses nearly a dozen factors, including age, ethnicity and level of physical activity.

UC DAVIS RESEARCHERS DISCOVER NOVEL PATHWAY TO INCREASED INFLAMMATION IN DIABETES PATIENTS  
November 27, 2007 —  Researchers at UC Davis Health System have discovered a novel pathway that results in increased inflammation of blood vessels in patients with type 1 diabetes.

UC DAVIS RESEARCHERS FIND EVIDENCE OF MATURE HEART CELL POTENTIAL IN EMBRYONIC STEM CELLS  
November 27, 2007 —  In a new study, UC Davis researchers report the first functional evidence that heart cells derived from human embryonic stem cells exhibit one of the most critical properties of mature adult heart cells, an important biological process called excitation-contraction coupling.

NEW GUIDELINES FOR FRUIT AND VEGETABLE CONSUMPTION MAY NOT BE FEASIBLE FOR LOW-INCOME FAMILIES  
November 19, 2007 —  To meet current dietary guidelines, low-income families would have to spend much more of their food budgets on fruits and vegetables than they may be able to afford, according to UC Davis research published in the November issue of the Journal of the American Dietetic Association.

UC DAVIS PHYSICIAN HONORED FOR USING TOBACCO-INDUSTRY DOCUMENTS TO EDUCATE THE PUBLIC 
November 1, 2007 —  Elisa Tong, an assistant je;; professor of internal medicine, has been honored for her work in using tobacco industry documents to improve public awareness about the marketing practices and issues surrounding the nation's use of tobacco.

UC STUDY UNCOVERS TOBACCO INDUSTRY EFFORTS TO UNDERMINE SECONDHAND SMOKE LINK TO CARDIOVASCULAR DISEASE
October 15, 2007 —  After combing through nearly 50 million pages of previously secret internal, tobacco industry documents, UC Davis and UC San Francisco researchers say they have documented for the first time how the industry funded and used scientific studies to undermine evidence linking secondhand smoke to cardiovascular disease.

AIR POLLUTION LINKED TO BRONCHITIS IN PRESCHOOLERS
October 11, 2007 —  In one of the first studies to examine air pollution in relation to infant and early childhood health, a UC Davis researcher has discovered a strong link between exposure to components of air pollution and acute bronchitis diagnoses in preschool-aged children.

PHYSICIANS SAY TIME AND MONEY CONSTRAINTS, OTHER BARRIERS HINDER CARE FOR DEMENTIA
October 11, 2007 —  Built-in limitations of the health-care system in the United States, such as time and reimbursement constraints, inhibit the ability of primary care doctors to best meet the needs of dementia patients and their families, according to a new study by researchers at UC Davis Health System.

UC DAVIS JOINS NATIONAL CHILDREN'S STUDY
October 4 — UC Davis Health System has been selected as a new site for the National Children's Study, which is assessing the effects of environmental and genetic factors on 100,000 children from before birth to age 21 in the United States. It is the largest study of child and human health ever conducted in the United States.

STUDY IDENTIFIES GENETIC RISK FACTOR FOR RHEUMTOID ARTHRITIS, LUPUS
September 7, 2007 —  A genetic variation has been identified that increases the risk of two chronic, autoimmune inflammatory diseases: rheumatoid arthritis and systemic lupus erythematosus.

UC DAVIS RECEIVES $21.8 MILLION TO FIND TREATMENTS THAT REVERSE COMMON CAUSE OF DEMENTIA IN OLDER ADULTS
September 6, 2007 —  The same research team who discovered an age-related neurological disorder will now receive $21.8 million from the National Institutes of Health (NIH) to develop new treatments for it.

TWO STUDIES EXAMINE PHYSICIANS-IN-TRAINING WORK HOURS REFORM ON MORTALITY AMONG HOSPITALIZED PATIENTS
September 5, 2007 —  Researchers, including an investigator from UC Davis Health System, have found that new national regulations greatly limiting work hours for physicians-in-training did not lead to increased patient deaths.

UC DAVIS GRANT TO EXAMINE WHETHER FISH OILS WILL HELP REVERSE KIDNEY DISEASE
August 29, 2007 —  A two-year pilot research grant awarded to physicians and scientists in the entomology, food science and technology, and internal medicine departments at UC Davis may determine if omega 3-fatty acids, commonly found in fish oils, can help reverse a chronic inflammatory disease of the kidneys.

DERMATOLOGY RESEARCHER RECEIVES GRANT FOR NEW PHYSICIAN-SCIENTISTS
August 17, 2007 —  An assistant professor of dermatology at the UC Davis School of Medicine is among the recipients of a $375,000 grant awarded by the Howard Hughes Medical Institute as part of its effort to ensure that young, promising physician-scientists have the resources they need to launch their careers.

UC DAVIS RESEARCHER AWARDED GRANT TO DEFINE PSYCHIATRIC ISSUES OF FRAGILE X CARRIERS
August 8, 2007 —  UC Davis M.I.N.D. Institute researcher David Hessl has received a five-year $1.5 million grant from the National Institute of Mental Health to study men who are carriers of the gene that causes fragile X syndrome, a common cause of mental impairment. Hessl's study will identify whether or not psychiatric problems affect carriers of the gene mutation.

AMERICAN HEART ASSOCIATION AWARDS GRANT TO UC DAVIS POSTDOCTORAL FELLOW
July 23, 2007 —  The Western States Affiliate of the American Heart Association has awarded an $81,000 grant to UC Davis postdoctoral fellow Andrea Bechtold, supporting her for two years as she conducts research into the immediate benefits of exercise for those with high blood pressure.

DIET VERY HIGH IN FRUIT, VEGETABLES AND FIBER AND LOW IN FAT DOES NOT APPEAR TO REDUCE RISK OF BREAST CANCER RECURRENCE MORE THAN THE “5-A-DAY” DIET
July 18, 2007 —  Women with early stage breast cancer who adopted a diet very high in vegetables, fruit and fiber and low in fat did not have a lower risk of breast cancer recurrence compared to women who followed a diet of five or more servings a day of fruit and vegetables (the “5-A-Day” diet), according to a study in the July 18 issue of the Journal of the American Medical Association.

STATIN THERAPY LOWERS RISK OF CORONARY ARTERY DISEASE IN YOUNG PATIENTS WITH TYPE 1 DIABETES
June 20, 2007 —  UC Davis researchers have found that low doses of simvastatin, part of a class of medications widely used to lower cholesterol, reduced the major risk factors for coronary artery disease in young patients with Type 1 diabetes, indicating that the use of these drugs could reduce their risk later in life for this condition, the main cause of death in these patients.

THERMOGENESIS AND UNIVERSITY OF CALIFORNIA, DAVIS STEM CELL PROGRAM COLLABORATE TO DEVELOP STEM CELL TREATMENTS FOR MAJOR DISEASES
June 19, 2007 —  ThermoGenesis Corp. and the Stem Cell Program at the University of California, Davis today announced a collaborative research agreement to develop stem cell therapies based upon ThermoGenesis' AutoXpress™, BioArchive® and CryoSeal® FS blood processing systems.

FIRST COMPACT PROTON THERAPY MACHINE FOR CANCER TREATMENT ENTERS DEVELOPMENT
June 14, 2007 —  With a technology transfer agreement announced today, the first compact proton therapy system — one that would fit in any major cancer center and cost a fifth as much as a full-scale machine — is one step closer to reality.

STUDY OF GUN SHOWS FINDS CALIFORNIA LAWS REDUCE ILLEGAL GUN PURCHASES WITHOUT LIMITING LEGITIMATE GUN SALES
June 12, 2007 — The potential for gun shows to serve as places where criminals obtain firearms can be curbed through increased regulation without adversely affecting attendance or business, according to a pioneering study published this week in Injury Prevention, an international peer-reviewed journal for health professionals.

—MEDIA ADVISORY—
“UNDERCOVER” STUDY OF GUN SHOWS FINDS CALIFORNIA LAWS REDUCE ILLEGAL GUN PURCHASES WITHOUT LIMITING LEGITIMATE GUN SALES
June 7, 2007 — Study documents more undocumented, private-party gun sales and illegal “straw” purchases outside of California.

UC DAVIS WINS STATE APPROVAL FOR STEM CELL RESEARCH FACILITY FUNDING
June 6, 2007 — At the June 5 meeting of the California Institute for Regenerative Medicine's Independent Citizens Oversight Committee (ICOC), members awarded UC Davis $2.8 million over three years for the Translational Human Embryonic Stem Cell Shared Research Facility.

USAID GRANT FUNDS UC DAVIS PARTNERSHIP TO IMPROVE TB DIAGNOSIS IN PAKISTAN
June 4, 2007 —  UC Davis and Pakistani researchers have received a grant from the U.S. Agency for International Development (USAID) to develop a better method for diagnosing tuberculosis that employs novel technology and is highly effective, affordable and portable, which will allow it to be deployed in remote, rural areas of the world.

GENE VARIATIONS MAY ACCOUNT FOR JAPAN-U.S. DIFFERENCES IN SUCCESS OF LUNG CANCER TREATMENT
June 2, 2007 —  Last year, a groundbreaking international project found that a group of Japanese patients with advanced non-small cell lung cancer survived longer — and had a higher rate of side effects — than U.S. patients with the same diagnosis when both groups were given two well-known drugs for the disease.

UC DAVIS, UC MERCED AND BUCK INSTITUTE COOPERATE TO MEET STEM CELL OVERSIGHT REQUIREMENTS
May 18, 2007 — Taking a cue from the state's stem cell agency, which has galvanized stem cell research and opened up lines of communication among researchers in California, scientists at the University of California, Merced and the Buck Institute for Age Research in Marin County have established a cooperative agreement with UC Davis to meet the oversight requirements of the California Institute for Regenerative Medicine (CIRM) for stem cell research.

UC DAVIS CLINICAL AND TRANSLATIONAL SCIENCE CENTER AWARDS SEVEN PILOT GRANTS FOR INNOVATIVE RESEARCH
May 17, 2007 — The UC Davis Clinical and Translational Science Center awarded seven pilot grants ranging from $10,000 to $30,000 to faculty members conducting a variety of innovative research projects, from a new imaging procedure for intraoperative identification of tumors to understanding HPV vaccine disparities in lower socioeconomic communities.

TWO UC DAVIS MEDICAL STUDENTS AWARDED PRESTIGIOUS RESEARCH FELLOWSHIPS
May 8, 2007 — Two UC Davis School of Medicine students have been awarded research training fellowships from the Howard Hughes Medical Institute.

UC DAVIS RESEARCHERS WIN GRANT FOR LATINO PALLIATIVE CARE CANCER STUDY
May 1, 2007 —  UC Davis researchers have received a two-year, $144,000 grant from the American Cancer Society's new Palliative Care Initiative to develop and test a Spanish-language educational program for Latino cancer patients and their caregivers.

STUDY SEEKS TO DEVELOP RULES FOR SAFER USE OF CT SCANNING ON CHILDREN WITH INTRA-ABDOMINAL INJURIES
April 12, 2007 —  James F. Holmes, associate professor of emergency medicine at UC Davis Health System, has received a three-year, $1.3 million grant to develop criteria for determining when computed tomography (CT) should be used on children with intra-abdominal injuries.

PATIENT SPOTLIGHT TO FOCUS ON PERIPHERAL VASCULAR DISEASE, TREATING DAMAGED BLOOD VESSELS
April 6, 2007 — At next week's meeting of the California Institute for Regenerative Medicine, UC Davis experts will discuss state-of-the-art treatment for peripheral vascular disease and focus on the potential of stem cell and embryonic stem cell research to improve patient care in our lifetime.

UC DAVIS STUDY FINDS HIGH ARSENIC LEVELS IN HERBAL KELP SUPPLEMENTS
April 5, 2007 — A study of herbal kelp supplements led by UC Davis public health expert Marc Schenker concludes that its medicinal use may cause inadvertent arsenic poisoning and health dangers for consumers, especially when overused.

U.S. NEWS & WORLD REPORT RANKS UC DAVIS SCHOOL OF MEDICINE AMONG BEST FOR PRIMARY CARE, RESEARCH
March 30, 2007 — U.S. News & World Report once again includes the UC Davis School of Medicine as among the best in the country for primary care and research in the magazine's annual list of America's best graduate schools.

GENERAL PHYSICALS PROMPT PATIENTS TO GET NEEDED CANCER SCREENINGS, STUDY FINDS
March 26, 2007 — If you're 50 or older, seeing your doctor every year or two for a checkup may be a good defense against cancer, according to a new study by researchers at UC Davis, the University of Washington, and Group Health Cooperative in Seattle.

OPTIMAL TREATMENT OFTEN NOT PROVIDED TO PATIENTS WITH ACUTE CORONARY SYNDROMES
March 26, 2007 —  Studies have shown that patients who arrive at the hospital with acute coronary syndromes benefit from early intensive treatment.

NEW REPORT WARNS CONGRESS ABOUT CONTINUED FLAT FUNDING OF BIOMEDICAL RESEARCH
March 20, 2007 —  The director of the UC Davis Women's Cardiovascular Medicine Program participated in a consortium of eight leading scientific and medical institutions around the country that Monday warned Congress that persistent flat-funding of biomedical research could thwart advances in treatments for such diseases as cancer and Alzheimer's disease.

UC DAVIS RESEARCHERS AWARDED MORE STEM CELL FUNDS
March 16, 2007 —  California's stem cell agency has awarded another pair of grants worth an estimated $5 million to UC Davis School of Medicine scientists conducting regenerative medicine research.

UC DAVIS RESEARCHERS USE HEATED NANOPROBES TO DESTROY BREAST CANCER CELLS IN MICE
March 6, 2007 —  In experiments with laboratory mice that bear aggressive human breast cancers, UC Davis researchers have used hot nanoprobes to slow the growth of tumors - without damage to surrounding healthy tissue.

UC DAVIS RESEARCHERS DISCOVER KEY TO BODY'S ABILITY TO DETECT SUBTLE TEMPERATURE CHANGES
February 26, 2007 —  Scientists have long known the molecular mechanisms behind most of the body's sensing capabilities. Vision, for example, is made possible in part by rhodopsin, a pigment molecule that is extremely sensitive to light.

METHAMPHETAMINE USE LINKED TO HIGHER RISK OF CARDIOMYOPATHY IN YOUNG PATIENTS
February 23, 2007 —  Young people who use methamphetamine, an addictive, illegal stimulant also known as meth, crank, crystal and speed, more than triple their risk of cardiomyopathy, a disease of the heart muscle, according to a study led by a researcher at UC Davis Health System.

TWO UC DAVIS RESEARCHERS RECEIVE GRANTS TO STUDY EMBRYONIC STEM CELLS
February 16, 2007 —  Two UC Davis researchers are among scientists from around the state who were awarded seed-grant funding from the California Institute of Regenerative Medicine today.

UC DAVIS RESEARCHERS TO STUDY IMPACT OF ANCESTRY GENES ON WOMEN'S HEALTH
January 29, 2007 —  UC Davis researchers will conduct a first-of-its-kind genetic study to determine the importance of ancestry on the development of diseases in women, thanks to a grant of nearly $1.4 million from the National Heart, Lung, and Blood Institute.

VOLUNTEERS SOUGHT FOR STUDY OF ANCESTRY AND PROSTATE CANCER IN AFRICAN-AMERICAN MEN
January 16, 2007 —  A new study under way at UC Davis Cancer Center may help doctors see beyond skin color when it comes to decisions about prostate-cancer screening and treatment for African-American men.

SPORTS-FORMULATED JELLY BEANS JUST AS EFFECTIVE AS SPORTS DRINKS, GELS IN IMPROVING EXERCISE PERFORMANCE
December 8, 2006 —  Sports-formulated jelly beans were just as effective as popular sports drinks and gels in maintaining blood sugar levels and improving exercise performance among competitive endurance athletes who participated in a study by researchers from the UC Davis Sports Medicine Program.

UC DAVIS RESEARCHERS FIND INSECT PROTEIN EFFECTIVE FOR TREATING HEART ENLARGEMENT, ARRYTHMIAS
November 20, 2006 —  Compounds known to play an important role in how insects develop from larvae to adults have been shown in a mouse model for congestive heart failure to be effective in preventing and reducing cardiac cell overgrowth and irregular heart rhythms, according to UC Davis research published in the early online edition of the Proceedings of the National Academy of Sciences.

NEW DRUGS AIMED AT T CELLS SUCCESSFULLY TREAT ARTHRITIS AND DIABETES IN RATS
November 8, 2006 —  Researchers at UC Davis, UC Irvine and other institutions have developed new drugs that successfully treated rheumatoid arthritis and prevented the onset of Type 1 diabetes in animals via a cellular structure long suspected of playing a key role in those diseases.

NEW UC DAVIS CENTER LAUNCHES PILOT MEDICAL RESEARCH PROJECTS
October 19, 2006 —  As part of its newly established Clinical and Translational Science Center, six UC Davis School of Medicine faculty members have been awarded the first grants in a program designed to foster collaborative research and ultimately enable basic science to be translated into new prevention programs or treatments that will be widely available in all communities and for all patients.

FREE COMMUNITY LECTURE: HARNESSING LIGHT POWER — THE FUTURE OF MEDICINE
October 13, 2006 —  UC Davis Center for Biophotonics Science and Technology chief education officer Marco Molinaro will speak about the fundamentals of biophotonics, followed by a hands-on demonstration of non-invasive technologies to monitor health and a discussion of cutting-edge biophotonics research at a free public lecture on Tuesday, Oct. 17, at 7:30 p.m. in the Davis Branch of the Yolo County Library, 314 E. 14th St., Davis.

NATIONAL INSTITUTES OF HEALTH RESEARCH GRANTS PROVIDE BOOST TO UC DAVIS SCHOOL OF MEDICINE
October 11, 2006 —  The UC Davis School of Medicine ranked 44th among the nation's 123 medical schools in research funding from the National Institutes of Health in fiscal year 2005, up from 62nd place just five years ago.

ORANGE JUICE BEVERAGE FORTIFIED WITH PLANT STEROLS LOWERS INDICATORS OF HEART DISEASE RISK
October 10, 2006 —  Plant cholesterols known as sterols — recognized for their cholesterol-lowering power when added to margarines, salad dressings and other fats — also have been found to be effective in reducing low-density lipoprotein, or “bad” cholesterol” levels, when added to orange juice.

UC DAVIS AT FOREFRONT OF NATIONAL INITIATIVE TO TRANSFORM RESEARCH TO IMPROVE HUMAN HEALTH
October 3, 2006 —  The National Institutes of Health today named UC Davis as part of a national consortium that will transform how clinical and translational research is conducted, enabling researchers to provide new treatments more efficiently and quickly to patients.

STEM CELL RESEARCH: THE NEXT GENERATION
September 28, 2006 —  Medical student Joyce Ma is among 10 graduate students and postdoctoral fellows chosen for a new training program in stem cell research at the University of California, Davis.

UC DAVIS CHILDREN'S HOSPITAL RESEARCHER PINPOINTS GENETIC CAUSE OF CRANIOFACIAL BIRTH DEFECT
September 27, 2006 —  A research team led by a UC Davis Children's Hospital scientist has identified a genetic mutation as the cause of a congenital craniofacial birth defect called cranio-lenticulo-sutural dysplasia.

UC DAVIS STUDY FINDS DISTINCT GENETIC PROFILES FOR NORTHERN, SOUTHERN EUROPEANS
September 14, 2006 —  An international team of scientists led by researchers at UC Davis Health System has found that, with respect to genetics, modern Europeans fall into two groups: a Northern group and a Southern, or Mediterranean one.

UC DAVIS RESEARCHERS FIND ADDED BENEFIT OF STATINS IN THOSE AT HIGH RISK FOR HEART DISEASE, DIABETES
September 12, 2006 —  UC Davis researchers have shown that statins not only improve cholesterol levels, but also dramatically reduce disease-causing inflammation in patients with metabolic syndrome — a condition defined by symptoms that include abdominal obesity and high blood pressure.

EL DORADO HILLS COUPLE FUNDS NEW TOURETTE'S SYNDROME RESEARCH PROGRAM
September 7, 2006 —  A couple from El Dorado Hills has agreed to underwrite the majority of funding needed to create a new Tourette's syndrome research and clinical program within the UC Davis M.I.N.D. Institute.

BETTER AFTER-SCHOOL SNACK CHOICES BOOST NUTRITION FOR LOW-INCOME KIDS, UC DAVIS RESEARCH CONFIRMS
August 30, 2006 —  School lunches and vending machines aren't the only places to look for ways to improve students' nutrition. Modest changes in the kinds of snacks offered at after-school programs can also have a significant positive impact on children's diets, UC Davis researchers report in the September 2006 issue of the American Journal of Public Health.

UC DAVIS RESEARCHERS MOVE BIOTECHNOLOGY CLOSER TO REPLACING ELECTRONIC PACEMAKERS
August 22, 2006 —  UC Davis researchers have successfully used a custom designed protein and gene delivery system to restore normal heart rhythms in pigs with electronic pacemakers, reducing their dependence on implanted devices.

UC DAVIS STUDY FINDS BRAIN CELL REGULATOR IS VOLUME CONTROL, NOT ON/OFF SWITCH
August 17, 2006 —  UC Davis researchers have discovered that proteins that regulate brain-cell activity by controlling the flow of potassium ions behave more like volume controls on stereos rather than on/off power switches.

UC DAVIS RESEARCHER RECOGNIZED AS AN OUTSTANDING YOUNG NEUROSCIENTIST
August 16, 2006 —  A. Kimberley McAllister, associate professor of neurology, has been named a Young Investigator of the Year by the Society for Neuroscience, the world's largest professional organization representing scientists and physicians dedicated to understanding the brain, spinal cord and peripheral nervous system.

UC DAVIS STUDY FINDS HIV HIDING FROM DRUGS IN GUT, PREVENTING IMMUNE RECOVERY
July 29, 2006 — UC Davis researchers have discovered that the human immunodeficiency virus, the virus that causes AIDS, is able to survive efforts to destroy it by hiding out in the mucosal tissues of the intestine. They also found that HIV continues to replicate in the gut mucosa, suppressing immune function in patients being treated with antiretroviral therapy-even when blood samples from the same individuals indicated the treatment was working.

LEADING VASCULAR SPECIALIST NAMED DIRECTOR OF UC DAVIS VASCULAR CENTER
July 28, 2006 — John R. Laird, a leader in the field of peripheral vascular intervention, has been named as the medical director of the UC Davis Vascular Center , which is dedicated toward providing state-of-the-art vascular care and promoting collaboration among the different specialties involved In the treatment of patients with vascular disease.

TAMOXIFEN FOR BREAST CANCER PREVENTION DOES NOT BENEFIT MOST WOMEN, UC DAVIS RESEARCH SHOWS
July 24, 2006 —  Most women at high risk for breast cancer do not increase their life expectancy by taking the drug tamoxifen, according to a new analysis.

UC DAVIS LANDS TOP STEM CELL EXPERT AND LAB DIRECTOR FOR NEW RESEARCH PROGRAM IN SACRAMENTO
July 12, 2006 —  UC Davis Vice Chancellor for Human Health Sciences Claire Pomeroy today announced the successful recruitment of Jan A. Nolta as director of the university's new stem cell research program and Gerhard Bauer as the program's specialized cell and gene therapy laboratory director.

UC DAVIS RESEARCHERS REPORT ADVANCE THAT MAY LEAD TO MUCH-NEEDED TEST FOR OVARIAN CANCER
July 7, 2006 —  A team of UC Davis Cancer Center researchers has identified a biomarker profile test for ovarian cancer, an advance that may lead to an early test for the disease.

UC DAVIS PHYSICAN RECEIVES AWARD FOR RESEARCH INTO DIRECT-TO-CONSUMER DRUG ADVERTISING
June 30, 2006 —  AcademyHealth, the national organization for health services research and policy, has honored Richard L. Kravitz with its 2006 “Best Published Research Paper of the Year Award” for his lead authorship in an article about direct-to-consumer drug advertising.

UC DAVIS TRAINING THE NEXT GENERATION OF RESEARCHERS IN WOMEN'S HEALTH
June 26, 2006 —  Despite remarkable advances in women's health during the past century, it wasn't until the early 1990s that medical researchers, practitioners, and policy makers began to directly address the issue of sex-based and gender-based differences in disease.

UC DAVIS RESEARCHERS REPORT NEW MOLECULE THAT TARGETS LEUKEMIA AND LYMPHOMA CELLS
June 12, 2006 —  UC Davis Cancer Center researchers have developed a novel peptide that binds to the surface of leukemia and lymphoma cells with extremely high affinity, specificity and stability, and demonstrates remarkable promise as a tool to help image tumors and deliver anti-cancer drugs.

TUMOR RESPONSE MAY NOT BE BEST MEASURE OF EFFICACY IN NON-SMALL CELL LUNG CANCER TREATMENT
June 5, 2006 —  Researchers typically evaluate the effectiveness of a new cancer treatment by looking at how tumors respond to it. But in the case of advanced non-small cell lung cancer, there may be a better way to assess effectiveness.

NEW DRUG EXTENDS LUNG CANCER SURVIVAL 22 PERCENT, UC DAVIS CANCER CENTER RESEARCHERS REPORT
June 5, 2006 —  Adding the new molecularly targeted agent bortezomib to a standard chemotherapy regimen of gemcitabine and carboplatin prolongs survival in patients with advanced non-small cell lung cancer, according to final results from a national phase II trial.

UC DAVIS RESEARCHERS REVEAL APPLES' PROTECTIVE WAYS
May 17, 2006 —  Doctors have long been encouraging Americans to add more fruits and vegetables to their daily diets.

UC DAVIS STUDY ON DRUG ADVERTISING IS “BEST PUBLISHED RESEARCH PAPER OF THE YEAR”
May 1, 2006 —  A UC Davis study that showed patients' requests for specific medications can have a profound effect on physicians prescribing medications for major depression has been selected for the “Best Published Research Paper of the Year Award” by the Society of General Internal Medicine.

UC DAVIS RECEIVES STATE'S FIRST STEM CELL FUNDS
April 10, 2006 — UC Davis will be among 16 nonprofit institutions around the state receiving the first stem cell grant funding from California's Institute for Regenerative Medicine (CIRM). CIRM distributed nearly $900,000 to UC Davis for a new and comprehensive program designed specifically to train young physician/scientists in stem cell research.

JELLY BEANS AMONG SUPPLEMENTS TO BE STUDIED FOR EFFECTIVENESS IN IMPROVING EXERCISE PERFORMANCE AND WARDING OFF FATIGUE AFTER EXERCISE
April 10, 2006 — Researchers from the UC Davis Sports Medicine Program and Nutrition Department are using competitive endurance athletes in a study that will compare the effectiveness of three different forms of carbohydrate supplementation — including jelly beans (sports beans) — versus plain water in improving athletic performance and warding off fatigue after prolonged exercise.

UC DAVIS, LAWRENCE LIVERMORE RESEARCHERS DEVELOP BETTER, SAFER TEST FOR PERNICIOUS ANEMIA
April 4, 2006 — A team of scientists and a physician at the University of California, Davis, and Lawrence Livermore National Laboratory have developed a safer, more accurate test for pernicious anemia and other conditions related to the poor absorption of vitamin B12.

UC DAVIS STUDY SHOWS GRAPE SEED EXTRACT MAY BE EFFECTIVE IN REDUCING BLOOD PRESSURE
March 26, 2006 — Grape seed extract lowered the blood pressure of patients who participated in a UC Davis study of the benefits of the supplement on people with high blood pressure.

UC DAVIS STUDY WITH MICE LINKS THIMEROSAL WITH IMMUNE SYSTEM DYSFUNCTION
March 21, 2006 — A team of cell biologists, toxicologists and molecular bioscientists at UC Davis has published a study connecting thimerosal with disruptions in antigen-presenting cells known as dendritic cells obtained from mice.

UC DAVIS M.I.N.D. INSTITUTE LAUNCHES LARGEST BIOMEDICAL ASSESSMENT OF CHILDREN WITH AUTISM
March 8, 2006 — Multidisciplinary teams of physicians and scientists at the University of California, Davis, M.I.N.D. Institute have launched the nation's most comprehensive assessment of children with autism to detect the biological and behavioral patterns that define subtypes of the disorder.

BRIDGING THE GAP BETWEEN BASIC SCIENCE AND MEDICAL PRACTICE
February 17, 2006 — The UC Davis School of Medicine is among 13 innovative graduate programs in the nation to receive funds from the Howard Hughes Medical Institute to foster the translation of basic science discoveries into new medical treatments.

UC DAVIS RESEARCHERS TUNING INTO CELLS' CHANNELS
February 16, 2006 — Nearly one-third of human genes are responsible for making cell-wall proteins, half of which are gatekeeper molecules called ion channels.

STUDY FINDS SIGNIFICANT REDUCTION IN RESPIRATORY ILLNESSES IN BABIES BREASTFED SIX MONTHS VS. FOUR
February 6, 2006 — Babies fully breastfed for six months are less likely to suffer from respiratory illnesses in their first two years than babies fully breastfed for only four months, according to research conducted by investigators at UC Davis Children's Hospital, the University of Rochester and the American Academy of Pediatrics, Center for Child Health Research.

BIOPHOTONICS HEADQUARTERS DEDICATED
January 30, 2006 — A new science — biophotonics — has a new center of operations. Quarters for the National Science Foundation-funded UC Davis Center for Biophotonics Science and Technology were dedicated Monday in the Oak Park Research Building at 2700 Stockton Blvd. Known as CBST, the biophotonics center is a research hub for roughly 100 investigators at nine institutions across the United States.

—MEDIA ADVISORY—
ST. HOPE ACADEMY STUDENTS TO HELP DEDICATE $20 MILLION OAK PARK RESEARCH BUILDING OPENING
January 26, 2006 —  State-of-the-art facility will be a biophotonics learning hub for area schools.

M.I.N.D. INSTITUTE LAB FOCUSES ON GENETIC CAUSES OF COGNITIVE IMPAIRMENTS
January 9, 2006 — Discovering how the brains of children with neurodevelopmental disorders differ from those of their typically developing peers is the focus of the new Cognitive Analysis and Brain Imaging Laboratory at the UC Davis M.I.N.D. Institute.

UC DAVIS RESEARCHERS COLLABORATE TO ADVANCE KNOWLEDGE OF TOURETTE SYNDROME
December 22, 2005 — Researchers in neurology, psychology and genetics at UC Davis are launching a collaborative research program on Tourette syndrome.

BREAST CT IS MORE COMFORTABLE THAN MAMMOGRAPHY AND MAY DETECT TUMORS BETTER, RESEARCH SHOWS
December 2, 2005 — Breast CT, an investigational technology for early breast cancer detection, may be better than mammography at detecting breast lesions and is much more comfortable for women, researchers from the University of California, Davis reported today at the annual meeting of the Radiological Society of North America in Chicago.

UC DAVIS RESEARCHERS DISCOVER GENETIC SWITCH INVOLVED IN CELLS’ RESPONSE TO RADIATION THERAPY
November 15, 2005 —  UC Davis Cancer Center researchers have discovered a genetic switch that causes cancer cells to become more sensitive to a drug administered to enhance radiation therapy effectiveness.

UC DAVIS RESEARCHERS SHED NEW LIGHT ON HOW CHEMOTHERAPY-INDUCED LEUKEMIA DEVELOPS
November 15, 2005 —  Topoisomerase II inhibitors are among the most successful chemotherapy drugs used to treat human cancer. But a small percentage of patients treated with these agents recover from their initial malignancy only to develop a second cancer, leukemia.

DRUG DEVELOPED AT UC DAVIS MAY PREVENT BREAST CANCER, TREAT POST-MENOPAUSAL VAGINAL ATROPHY
November 1, 2005 — A tamoxifen-like drug developed by UC Davis and Finnish researchers, now in clinical testing as a treatment for vaginal atrophy, may also help to prevent breast cancer, two preliminary studies suggest.

RESEARCHERS REPORT NEW DRUG-DELIVERY APPROACH
October 31, 2005 — Researchers at UC Davis Cancer Center and Lawrence Livermore National Laboratory have developed a promising new method of delivering targeted radiotherapy drugs to cancer patients. A report of their work appears in the online edition of the Proceedings of the National Academy of Sciences for the week of Oct. 31-Nov. 4.

UC DAVIS LOOKING FOR BETTER WAYS TO CONTROL CANCER PAIN
October 27, 2005 — Physicians and other cancer specialists working with the UC Davis Center for Health Services Research in Primary Care are stepping up their efforts to find more effective pain management techniques thanks to a $1.5 million grant from the American Cancer Society.

MORE THAN A THIRD OF WOMEN WITH OVARIAN CANCER REPORT SYMPTOMS OF THE DISEASE AT LEAST FOUR MONTHS BEFORE DIAGNOSIS
August 22, 2005 — Ovarian cancer is often thought of as a silent killer, coming to the attention of physicians only at its late stages when prognosis is poor. But according to a new study by UC Davis researchers, four in 10 women with ovarian cancer have symptoms that they tell their doctors about at least four months — and as long as one year — before they are diagnosed.

NATURALLY OCCURRING ASBESTOS LINKED TO LUNG CANCER
July 12, 2005 — Everyday exposure to naturally occurring asbestos increases the risk of developing malignant mesothelioma, according to a study by UC Davis researchers.

UC DAVIS STUDIES SHOW THAT GRAPE SEED EXTRACT MAY INHIBIT ARTERY HARDENING
June 27, 2005 — Adding grape seed extract to the diet may prevent atherosclerosis, according to three studies conducted by cardiovascular researchers at UC Davis School of Medicine and Medical Center.

UC DAVIS RESEARCHERS DISCOVER RECEPTOR PATHWAY FOR C-REACTIVE PROTEIN AND ITS EFFECTS ON HUMAN AORTIC ENDOTHELIAL CELLS
June 23, 2005 — For the first time, scientists have discovered how C-reactive protein, or CRP, is able to access endothelial cells. The UC Davis researchers' findings will be published in the July issue of Arteriosclerosis, Thrombosis, and Vascular Biology, one of the American Heart Association's leading journals.

TOBACCO LINKED TO 63 PERCENT OF CANCER DEATH BURDEN AMONG AFRICAN-AMERICAN MEN
June 13, 2005 — A new analysis links tobacco smoke to 63 percent of cancer deaths among African-American men in the United States.

STUDY DEMONSTRATES LONGEST REPORTED SURVIVAL RATE FOR LOCALLY ADVANCED LUNG CANCER PATIENTS
May 16, 2005 — An investigational chemoradiation regimen has achieved the best long-term survival rates yet reported in patients with locally advanced non-small cell lung cancer, according to results of a Phase II Southwest Oncology Group study presented today at the 41st annual meeting of the American Society of Clinical Oncology.

BREAST CT REACHES CLINICAL TESTING: MAY IMPROVE ON MAMMOGRAPHY
May 10, 2005 — A new breast screening technology that may be able to detect tumors earlier than mammography — without the need for uncomfortable breast compression — is being tested in patients at the University of California, Davis, Medical Center.

UC DAVIS RESEARCHER AWARDED GRANT TO STUDY HEALTH OF IMMIGRANT FARM WORKER FAMILIES
April 27, 2005 — Marc Schenker, a leading authority on occupational and environmental diseases and respiratory illness at the UC Davis School of Medicine, has received a research grant for more than $500,000 from the California Endowment to study the health of Mexican hired farm workers and their families.

DRUG ADVERTISING MAY INFLUENCE PHYSICIANS' PRESCRIBING DECISIONS
April 26, 2005 — Patients requesting specific medications can have a profound effect on physicians prescribing medications for major depression, according to a new study, led by researchers at the UC Davis School of Medicine and Medical Center, in the April 27 issue of the Journal of the American Medical Association.

MANY WOMEN AT HIGH RISK FOR BREAST CANCER RELUCTANT TO TAKE TAMOXIFEN TO REDUCE THEIR RISK
April 18, 2005 — Among women at high risk for breast cancer, fewer than one in five were inclined to take the drug tamoxifen to prevent the disease, according to researchers at the UC Davis School of Medicine and Medical Center.

BRAIN REGION RECOVERY POSSIBLE IN FORMER METHAMPHETAMINE USERS
April 4, 2005 — Adaptive changes in chemical activity in certain regions of the brain of former methamphetamine users who have not used the drug for a year or more suggest some recovery of neuronal structure and function, according to an article in the April issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

UC DAVIS RESEARCHERS DISCOVER NEW LINK BETWEEN C-REACTIVE PROTEIN, AND HEART DISEASE AND STROKE
March 22, 2005 — The cells that line the arteries are able to produce C-reactive protein, according to a study funded by the National Institutes of Health and published in the April issue of American Journal of Pathology.

BREAST CANCER IN ASIAN AMERICANS IS RISING FASTER THAN IN ANY OTHER ETHNIC GROUP
October 22, 2004 — The incidence of cancer among Asian Americans in California has dropped 5.9 percent and deaths from the disease have dropped 16.3 percent since 1988.

A NEW LAND, A NEW ILLNESS: HMONG FACE HIGH RATES OF CANCER ASSOCIATED WITH CHRONIC INFECTIONS
October 22, 2004 — Many of the 15,000 Hmong immigrants arriving in the United States this year will confront an illness that has no name in the Hmong language — cancer.

LATEST ASIAN-AMERICAN TOBACCO USE DATA REPORTED
October 22, 2004 — California's Asian Americans smoke at a lower rate than the state's population as a whole, but the better an Asian California woman's English.

SUPER-SIZING ASIAN AMERICANS
October 22, 2004 — Low-income Asian and Pacific Islander children in California are becoming overweightat an alarming rate — and will soon catch up to low-income white, black and Latino children in the proportion who are overweight or obese, according to research reported today at the 5th Asian American Cancer Control Academy.